ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Iterum Therapeutics (ITRM) Technical (Analysis) Reports Iterum Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Iterum Therapeutics (ITRM)

Technical Analysis Report for NASDAQ stock ITRM Iterum Therapeutics. Dated: 16 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ITRM Iterum Therapeutics then click here. or read Experts views on Iterum Therapeutics or Forecast & share price targets of Iterum Therapeutics

Iterum Therapeutics Opened at 0.32 and Closed at: 0.34, which is 5.88% of previous session's close. It moved within a range of 0.31 and 0.35
The session was a Bullish session with an average volume of 284044, which is 0.09% of previous session's volumes.

    A Golden cross was found 1 days back on short term averages

    Support for tomorrow is 0.33 and resistance for tomorrow is 0.37
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 0.32, 0.29 resistance for tomorrow's hourly charts is 0.36, 0.37

    10 Day SMA for Iterum Therapeutics (ITRM) is 0.34 and stock is trading above these levels. This is a good sign for its short term trend

    20 Day SMA for Iterum Therapeutics (ITRM) is 0.33 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Iterum Therapeutics (ITRM) is 0.41 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 0.55 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Iterum Therapeutics is 0.76 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Iterum Therapeutics is at 0.33 and 200 DMA is at 0.76, while 50 DMA and 100 DMA are at 0.41 and 0.55 respectively

    Iterum Therapeutics (ITRM) moving average of 20 SMA is at 0.33 and 20 EMA is at 0.36

    Iterum Therapeutics (ITRM) moving average of 50 SMA is at 0.41 and 50 EMA is at 0.44

    Iterum Therapeutics (ITRM) moving average of 100 SMA is at 0.55 and 100 EMA is at 0.57

    Iterum Therapeutics (ITRM) moving average of 200 SMA is at 0.76 and 200 EMA is at 0.82

    111 Inc has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in 111 Inc, about 64.48% more returns!

    Sutro Biopharma has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Sutro Biopharma, about 65.29% more returns!

    Strata Skin has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Strata Skin, about 16.22% more returns!

    Summit Therapeutics has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Summit Therapeutics, about 10.41% more returns!

    Scynexis Inc has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Scynexis Inc, about 13.7% more returns!

    Insulet Corporation has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Insulet Corporation, about 8.76% more returns!

    Medpace Holdings has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 19.58% more returns!

    Array Biopharma has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 17.68% more returns!

    Benitec Biopharma has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Benitec Biopharma, about 13.17% more returns!

    Celcuity Inc has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 18.4% more returns!

    Cocrystal Pharma has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Cocrystal Pharma, about 21.53% more returns!

    Cytokinetics Incorporated has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 11.14% more returns!

    Iterum Therapeutics has performed better than Evolus Inc in short term. Holding Iterum Therapeutics could be a better choice for now!

    Kalvista Pharmaceuticals has performed better than Iterum Therapeutics in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 7.86% more returns!

    Iterum Therapeutics Technical analysis of indicators

    Price action analysis of Iterum Therapeutics (ITRM) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

    ADX buy sell signal for Iterum Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a BUY signal for Iterum Therapeutics in short term but the buy signal is initial and weak.

    Iterum Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

    Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

    CCI has generated a buy signal for Iterum Therapeutics in short term but BUY signal is weak.

    RSI is generating a BUY signal in short term but buying is losing momentum.

    MRSI is in positive zone. This is a BUY zone

    Although the stock is in the BUY zone, but buying might be slowing down

    Stock of Iterum Therapeutics is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 0.34 and Iterum Therapeutics ITRM stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Iterum Therapeutics ITRM stock. Volume based technical analysis of Iterum Therapeutics ITRM stock is negative.

    Iterum Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock ITRM Iterum Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And ITRM Experts View which covers a lot of information including buying and selling signals

    ITRM future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Iterum Therapeutics or View Candle Stick Charts here

    Chart Iterum Therapeutics (ITRM)  Technical (Analysis) Reports Iterum Therapeutics [

    Videos related to: Iterum Therapeutics (ITRM) Technical (Analysis) Reports Iterum Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Iterum Therapeutics (ITRM)  Technical (Analysis) Reports Iterum Therapeutics [

     

    Back to top